Screening of bioactive compounds and ameliorative effects of Siwei granules on triple-negative breast cancer

CHENG Lin; WANG Xiaowen; WENG Bangbi; HUANG Wei

doi:10.6039/j.issn.1001-0408.2026.20.06

您当前的位置：

首页 >

文章列表页 >

Screening of bioactive compounds and ameliorative effects of Siwei granules on triple-negative breast cancer

更新时间：2026-10-29

- Screening of bioactive compounds and ameliorative effects of Siwei granules on triple-negative breast cancer
- ZHONGGUO YAOFANG Vol. 37, Issue 20, Pages: 2660-2666(2026)
- 作者机构：
  
  1.成都中医药大学药学院，成都　611130
  2.陆军军医大学第一附属医院药剂科，重庆　400038
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2026.20.06
  CLC： R965
- Received：20 May 2026，
  
  Revised：2026-10-08，
  
  Accepted：08 October 2026，
  
  Published：30 October 2026
- 稿件说明：
移动端阅览
程林,王晓雯,翁邦碧,等.四味颗粒改善三阴性乳腺癌的活性物质筛选及作用研究 [J].中国药房,2026,37(20):2660-2666.

CHENG Lin,WANG Xiaowen,WENG Bangbi,et al.Screening of bioactive compounds and ameliorative effects of Siwei granules on triple-negative breast cancer[J].ZHONGGUO YAOFANG,2026,37(20):2660-2666.
程林,王晓雯,翁邦碧,等.四味颗粒改善三阴性乳腺癌的活性物质筛选及作用研究 [J].中国药房,2026,37(20):2660-2666. DOI： 10.6039/j.issn.1001-0408.2026.20.06.

CHENG Lin,WANG Xiaowen,WENG Bangbi,et al.Screening of bioactive compounds and ameliorative effects of Siwei granules on triple-negative breast cancer[J].ZHONGGUO YAOFANG,2026,37(20):2660-2666. DOI： 10.6039/j.issn.1001-0408.2026.20.06.

摘要

目的

筛选四味颗粒改善三阴性乳腺癌（TNBC）的活性物质，并探讨其抗TNBC作用。

方法

采用网络药理学方法，筛选四味颗粒活性成分、对应靶点及TNBC相关靶点，构建“成分-靶点”互作调控网络，并进行基因本体（GO）、京都基因和基因组数据库富集分析。以MDA-MB-231、4T1细胞为对象，筛选四味颗粒抗TNBC的活性物质；以MDA-MB-231细胞为对象，探讨活性物质单用或联用对细胞凋亡、迁移、周期、活性氧（ROS）生成以及富集通路相关蛋白表达的影响。

结果

通过网络药理学方法共获得活性成分67个，成分靶点与TNBC靶点的交集靶点131个；核心关键作用靶点包括磷脂酰肌醇-4，5-二磷酸3-激酶催化亚基α等6个；交集靶点富集于增殖、含磷基团转移酶复合物、蛋白酪氨酸激酶活性等GO功能，以及磷脂酰肌醇3激酶（PI3K）/蛋白激酶B（Akt）、ROS等信号通路。通过细胞实验共筛选得到4个活性物质，其中熊果酸对2种细胞的半数抑制浓度为25 μmol/L，甘草查尔酮A、木犀草素、芦荟大黄素（仅对4T1细胞有作用）对2种细胞的半数抑制浓度均为50 μmol/L；4种物质单用（20 μmol/L）或联用（各10 μmol/L），可显著升高MDA-MB-231细胞的凋亡率（仅联合组）、相对ROS水平（仅联合组）和G

期细胞比例（仅木犀草素组、甘草查尔酮A组和联合组），并显著降低G

期细胞比例（仅甘草查尔酮A组和联合组）、划痕愈合率和PI3K（芦荟大黄素组除外）、Akt（芦荟大黄素组除外）、哺乳动物雷帕霉素靶蛋白的磷酸化水平（

＜0.05）。

结论

四味颗粒抗TNBC的活性物质可能为熊果酸、甘草查尔酮A、木犀草素、芦荟大黄素，这些物质可不同程度地抑制TNBC细胞增殖和迁移，促进其凋亡，阻滞细胞周期于G

期，诱导R

OS的生成，并抑制PI3K/Akt信号通路相关蛋白的磷酸化。

Abstract

OBJECTIVE

To screen for bioactive compounds in Siwei granules against triple-negative breast cancer （TNBC）， and explore their anti-TNBC effects.

METHODS

Network pharmacology was applied to screen bioactive compounds of Siwei granules， corresponding targets and TNBC-related targets. A “component-target” interaction regulatory network was constructed， followed by Gene Ontology （GO） and Kyoto Encyclopedia of Genes and Genomes （KEGG） enrichment analyses. Using MDA-MB-231 and 4T1 cells as subjects， bioactive compounds from Siwei granules against TNBC were screened. Using MDA-MB-231 cells as the subject， the effects of these bioactive compounds， either alone or in combination， on cell apoptosis， migration， cell cycle， reactive oxygen species （ROS） generation， and the expression of proteins related to enriched pathways were explored.

RESULTS

A total of 67 bioactive compounds were identified by network pharmacology， with 131 overlapping targets between the compound targets and TNBC targets. Six core key targets were identified， including the phosphatidylinositol-4，5-bisphosphate 3-kinase catalytic subunit alpha， etc. The overlapping targets were enriched in GO functions such as proliferation， phosphotransferase complexes， and protein tyrosine kinase activity， as well as in signaling pathways including phosphoinositide 3-kinase （PI3K）/protein kinase B （Akt） and ROS. A total of 4 bioactive compounds were identified by cell experiments. Among them， the half-maximal inhibitory concentration （IC

） of ursolic acid for both cell lines was 25 μmol/L， while that of licochalcone A， luteolin， and aloe-emodin （for 4T1 cells only） was 50 μmol/L for both cell lines. When administered alone （all 20 μmol/L） or in combination （10 μmol/L each）， the four compounds significantly increased the apoptosis rate in MDA-MB-231 cells （only in the

combination group only）， relative ROS levels （only in the combination group） and the proportion of cells in the G

phase （only in the luteolin group， licochalcone A group， and combination group）， while they significantly reduced the proportion of cells in the G

phase （only in the licochalcone A group and the combination group）， scratch healing rate， and the phosphorylation levels of PI3K （except in the aloe-emodin group）， Akt （except in the aloe-emodin group）， and the mammalian target of rapamycin （

＜0.05）.

CONCLUSIONS

The bioactive compounds in Siwei granules responsible for its anti-TNBC activity may be ursolic acid， licochalcone A， luteolin， and aloe-emodin； these compounds can， to varying degrees， inhibit TNBC cell proliferation and migration， promote apoptosis， arrest the cell cycle in the G

phase， induce ROS production， and inhibit the phosphorylation the related proteins of the PI3K/Akt signaling pathway.

关键词

Keywords

references

Han B F ， Zheng R S ， Zeng H M ， et al . Cancer incidence and mortality in China，2022 [J ] . J Natl Cancer Cent ， 2024 ， 4 （ 1 ）： 47 - 53 .

Karim A M ， Eun Kwon J ， Ali T ， et al . Triple-negative breast cancer：epidemiology，molecular mechanisms，and modern vaccine-based treatment strategies [J ] . Biochem Pharmacol ， 2023 ， 212 ： 115545 .

Wu G Y ， Xiao M Z ， Hao W C ， et al . Drug resistance in breast cancer：mechanisms and strategies for management [J ] . Drug Resist Updat ， 2025 ， 83 ： 101288 .

Yang Z M ， Zhang Q H ， Yu L H ， et al . The signaling pathways and targets of traditional Chinese medicine and natural medicine in triple-negative breast cancer [J ] . J Ethnopharmacol ， 2021 ， 264 ： 113249 .

Zhang Y B ， Ma X R ， Li H Y ， et al . Identifying the effect of ursolic acid against triple-negative breast cancer：coup-ling network pharmacology with experiments verification [J ] . Front Pharmacol ， 2021 ， 12 ： 685773 .

Ke D Y J ， El-Sahli S ， Wang L S . The potential of natural products in the treatment of triple-negative breast cancer [J ] . Curr Cancer Drug Targets ， 2022 ， 22 （ 5 ）： 388 - 403 .

魏天睿，田雨宁，张子彦，等 . 基于PI3K/AKT途径探讨乳腺癌与乳腺增生发病机制及中医药干预作用研究进展 [J ] . 内蒙古医科大学学报， 2025 （ 1 ）： 97 - 103 .

庄延双，蔡宝昌，张自力 . 网络药理学在中药研究中的应用进展 [J ] . 南京中医药大学学报， 2021 ， 37 （ 1 ）： 156 - 160 .

贾征，张双庆 . 中药有效成分抗肿瘤作用机制研究进展 [J ] . 国外医药（抗生素分册）， 2025 ， 46 （ 3 ）： 163 - 170 .

Thilagavathi R ， Priyankha S ， Kannan M ， et al . Compounds from diverse natural origin against triple-negative breast cancer：a comprehensive review [J ] . Chem Biol Drug Des ， 2023 ， 101 （ 1 ）： 218 - 243 .

张祺嘉钰，赵佩媛，孙静，等 . 山楂的化学成分及药理作用研究进展 [J ] . 西北药学杂志， 2021 ， 36 （ 3 ）： 521 - 523 .

Mallepogu V ， Sankaran K R ， Pasala C ， et al . Ursolic acid regulates key EMT transcription factors，induces cell cycle arrest and apoptosis in MDA-MB-231 and MCF-7 breast cancer cells，an in-vitro and in silico studies [J ] . J Cell Biochem ， 2023 ， 124 （ 12 ）： 1900 - 1918 .

Gupta K B ， Gao J ， Li X ， et al . Cytotoxic autophagy：a novel treatment paradigm against breast cancer using oleanolic acid and ursolic acid [J ] . Cancers ， 2024 ， 16 （ 19 ）： 3367 .

Li Y Y ， Li R ， Zeng Z W ， et al . Prediction of the mechanisms of Xiaoai Jiedu Recipe in the treatment of breast cancer：a comprehensive approach study with experimental validation [J ] . J Ethnopharmacol ， 2020 ， 252 ： 112603 .

Xiang F F ， Fan Y ， Ni Z H ， et al . Ursolic acid reverses the chemoresistance of breast cancer cells to paclitaxel by targeting miRNA-149-5p/MyD88 [J ] . Front Oncol ， 2019 ， 9 ： 501 .

Lu Q ， Chen W L ， Ji Y J ， et al . Ursolic acid enhances cytotoxicity of doxorubicin-resistant triple-negative breast cancer cells via ZEB1-AS1/miR-186-5p/ABCC1 axis [J ] . Cancer Biother Radiopharm ， 2022 ， 37 （ 8 ）： 673 - 683 .

Luo F Z ， Zhao J J ， Liu S ， et al . Ursolic acid augments the chemosensitivity of drug-resistant breast cancer cells to doxorubicin by AMPK-mediated mitochondrial dysfunction [J ] . Biochem Pharmacol ， 2022 ， 205 ： 115278 .

Wang Z N ， Zhang P P ， Jiang H ， et al . Ursolic acid enhances the sensitivity of MCF-7 and MDA-MB-231 cells to epirubicin by modulating the autophagy pathway [J ] . Molecules ， 2022 ， 27 （ 11 ）： 3399 .

廖佳伟，金晨，陈志，等 . 鸡血藤化学成分、药理作用研究进展及其质量标志物（Q-Marker）预测 [J ] . 中草药， 2023 ， 54 （ 20 ）： 6866 - 6877 .

Huang W C ， Su H H ， Fang L W ， et al . Licochalcone A inhibits cellular motility by suppressing E-cadherin and MAPK signaling in breast cancer [J ] . Cells ， 2019 ， 8 （ 3 ）： 218 .

Wu L ， Lin Y D ， Gao S Y ， et al . Luteolin inhibits triple-negative breast cancer by inducing apoptosis and autophagy through SGK1-FOXO3a-BNIP3 signaling [J ] . Front Pharmacol ， 2023 ， 14 ： 1200843 .

Wu H T ， Lin J ， Liu Y E ， et al . Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT/mTOR signaling pathway [J ] . Phytomedicine ， 2021 ， 81 ： 153437 .

Wang X Y ， Zhang L J ， Si H W . Combining luteolin and curcumin synergistically suppresses triple-negative breast cancer by regulating IFN and TGF-β signaling pathways [J ] . Biomed Pharmacother ， 2024 ， 178 ： 117221 .

Abdellatef A A ， Fathy M ， Mohammed A E I ， et al . Inhibition of cell-intrinsic NF-κB activity and metastatic abilities of breast cancer by aloe-emodin and emodic-acid isolated from Asphodelus microcarpus [J ] . J Nat Med ， 2021 ， 75 （ 4 ）： 840 - 853 .

Mandal S K ， Samanta S K . A perspective of PI3K/AKT/mTOR pathway inhibitors to overcome drug-resistance in breast cancer therapy [J ] . Curr Med Chem ， 2025 ， 32 （ 10 ）： 1865 - 1873 .

Dong C ， Wu J ， Chen Y ， et al . Activation of PI3K/AKT/mTOR pathway causes drug resistance in breast cancer [J ] . Front Pharmacol ， 2021 ， 12 ： 628690 .

尹沁怡，陈清光，许嘉慧，等 . 麦芽治疗高泌乳素血症的临床认识及研究进展 [J ] . 上海中医药杂志， 2023 ， 57 （ 3 ）： 93 - 97 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Study on the ameliorative effects and mechanisms of Coptidis Rhizoma-Ophiopogonis Radix herb pair in rats with type 2 diabetes mellitus

Cost-utility analysis of datopotamab deruxtecan as first-line treatment for advanced triple-negative breast cancer in patients ineligible for immunotherapy

Predictive screening， activity evaluation and quantitative analysis of hepatoprotective constituents from Thesium chinense Turcz.

Study on antidepressant effects and mechanisms of total triterpenes from Poriae Cutis

Prediction and verification of the mechanism of action of Jiawei qifang weitong granule in ameliorating precancerous lesions of gastric cancer

Related Author

LI Qiufang

LI Shaoyu

GONG Man

MA Rongzeng

WANG Mengmeng

ZHANG Qiongqiong

GAO Jinghong

DAI Liping

Related Institution

Henan Collaborative Innovation Center for Research and Development on the Whole Industry Chain of Yu-Yao， Henan University of Chinese Medicine

Reproductive Medicine Center， The Third Affiliated Hospital of Zhengzhou University

Hebei Association for Comprehensive Evaluation of Drugs and Health Technologies

College of Graduate， Hebei Medical University

Dept. of Pharmacy， The Third Hospital of Hebei Medical University

⁰